AI for GWAS and Population Genomics: Improving Power, Prioritization, and Interpretation

Genome-wide association studies (GWAS) have catalogued hundreds of thousands of genetic variants linked to complex human traits and diseases, with more than 625,000 variant-trait associations across more than 15,000 traits as of mid-2024. ML is now being applied at every stage of the artificial intelligence (AI) GWAS pipeline, from statistical association testing to clinical risk prediction, and the question for researchers is no longer whether ML adds value but where the improvements are genuine, how large they are, and which limitations remain.

What GWAS can and cannot tell us: The limits AI must address

GWAS identifies statistical associations between single nucleotide polymorphisms (SNPs) and phenotypes across large cohorts. The method does not, by itself, identify causal variants, causal genes, or biological mechanisms. Each genome-wide significant locus typically contains dozens to hundreds of variants in linkage disequilibrium (LD), the nonrandom coinheritance of alleles, making it impossible from association statistics alone to determine which variant drives the signal.

Figure 1: A five-stage flowchart illustrating the AI-assisted GWAS interpretation pipeline from association testing through functional annotation, polygenic risk score construction, and population stratification correction. Credit: AI-generated image created using Google Gemini (2026).

A further constraint is that over 90% of GWAS variants fall in noncoding regions of the genome. These variants do not alter protein-coding sequence directly; instead, they are presumed to affect gene regulation through promoters, enhancers, and other cis-regulatory elements. Linking a noncoding GWAS signal to a specific regulatory effect in the relevant cell type has historically required extensive experimental follow-up.

ML is not primarily changing how GWAS identifies associations; that statistical framework is well established. Its principal contributions are downstream: prioritizing candidate causal variants within associated loci, predicting regulatory consequences of noncoding variants, building more accurate polygenic scores from GWAS summary statistics, and correcting for confounders such as ancestry-related population stratification.

ML for variant prioritization and statistical fine-mapping

Fine-mapping is the process of narrowing an associated locus to the most likely causal variant or variants. Classical Bayesian fine-mapping methods, including SuSiE (sum of single effects) and FINEMAP, model the LD structure within a locus and compute posterior inclusion probabilities for each variant. These approaches work from GWAS summary statistics and a reference LD panel without requiring individual-level genotypes.

ML extends fine-mapping in two complementary ways. First, gradient boosting models trained on GWAS fine-mapping results can learn consensus variant-to-function scores that integrate evidence across functional genomics assays, including chromatin accessibility, histone modification, and transcription factor binding, and weight them according to their empirical relationship with causal variant status. These scores can then be incorporated as priors in Bayesian fine-mapping to improve resolution. Second, deep learning sequence models provide in silico variant effect predictions at nucleotide resolution that can further distinguish among fine-mapped candidates by predicted chromatin impact.

Table 1: Summary of key approaches for ML-assisted GWAS fine-mapping and variant prioritization.

Approach	Method type	Primary input	Key output
Bayesian fine-mapping (SuSiE)	Statistical	GWAS summary statistics, LD reference	Credible sets, posterior inclusion probabilities
Gradient boosting (e.g., cV2F score)	Supervised ML	Functional genomic features	Consensus variant-to-function score
Deep learning sequence models (DeepSEA)	Deep learning	DNA sequence	Chromatin effect prediction per variant
Enformer / AlphaGenome	Deep learning	DNA sequence, long-range context	Gene expression and regulatory activity predictions

Functional annotation with deep learning

The challenge of interpreting noncoding variants has driven substantial investment in sequence-based deep learning models trained to predict regulatory activity from DNA sequence alone. DeepSEA, published in Nature Methods in 2015, established the foundational approach: a convolutional neural network trained on large-scale chromatin profiling data that predicts noncoding variant chromatin effects at single-nucleotide resolution. The model demonstrated that predicted chromatin effects improved prioritization of noncoding GWAS SNPs beyond conservation-based scores.

Enformer, reported in Nature Methods in 2021, extended the approach by integrating long-range genomic interactions up to 100 kilobases, substantially improving gene expression prediction from sequence and enabling more accurate variant effect prediction. Enformer's architecture allows it to capture enhancer-promoter interactions relevant to many noncoding GWAS loci that shorter-context models miss. The more recent AlphaGenome model, published in Nature in 2026, addresses a fundamental trade-off between sequence context length and output resolution that constrained Enformer and related architectures, providing nucleotide-level predictions from longer genomic windows.

An important limitation is that benchmarking studies have found that deep learning variant effect scores provide relatively modest additional information beyond existing evolutionary conservation and regulatory element annotations when tested using stratified LD score regression. This does not mean the models are without value, as their predictions are enriched for trait heritability, but it suggests that current deep learning tools are most useful as one layer of evidence within an integrative prioritization framework rather than as standalone fine-mapping solutions.

Polygenic risk scores: Classical methods vs ML

A polygenic risk score aggregates effect estimates from GWAS variants across the genome into a single index of an individual's genetic predisposition to a trait or disease. The classical approach, clumping and thresholding, retains only genome-wide significant variants in approximate LD independence and sums their weighted allele counts. More sophisticated Bayesian regression methods, including LDpred2 and PRS-CS, model the full distribution of SNP effects and the LD structure, producing effect-size estimates that shrink toward zero for variants likely to reflect LD tagging rather than direct biological effect.

ML methods have more recently been applied to PRS construction. Gradient-boosted tree models incorporating SNP-level features alongside a classical PRS can capture nonlinear and interaction effects between variants that linear PRS models ignore. A study in Communications Biology demonstrated that combining a linear PRS with XGBoost features produced relative improvements in variance explained ranging from 22% for height to 100% for diastolic blood pressure across nine complex phenotypes in a multi-ancestry sample. A geometric deep learning approach, PRS-Net, reported in Genome Research in 2025, further modeled gene interaction networks within the PRS framework, outperforming linear methods across both disease and quantitative trait endpoints.

These ML-based PRS improvements are real but context-dependent. Gains are larger for traits with strong nonlinear genetic architecture and smaller for highly polygenic traits where linear models already capture most of the predictable variance. The additional computational cost of ML PRS methods is also higher than Bayesian regression approaches, which remains relevant for large-scale biobank applications.

How ML improves population stratification correction in GWAS

Population stratification, the systematic difference in ancestry between cases and controls in a GWAS cohort, is one of the most important confounders of genetic association analysis. If cases and controls differ in genetic ancestry, any variant with different allele frequencies between ancestries will show a spurious association with the trait of interest.

The standard correction is to include the top principal components of the genotype matrix as covariates in the regression model. PCA captures axes of ancestry variation, and including these components adjusts for the main stratification signal. Genomic control, an older approach, applies a global inflation correction factor to all association test statistics but treats all variants uniformly, which over-adjusts variants with small ancestry differentiation and under-adjusts those with large differentiation.

ML contributes to stratification correction principally by improving ancestry inference. Methods that classify individuals into ancestry groups using supervised classifiers, trained on reference panels with known ancestry, enable more precise matching of cases and controls and more accurate selection of covariates. These approaches are especially valuable in datasets combining individuals along the continuum of genetic ancestry rather than discrete population categories. Mixed-model methods such as BOLT-LMM and SAIGE incorporate genetic relatedness matrices to handle both population structure and cryptic relatedness simultaneously, outperforming PCA alone in large, diverse cohorts that contain family structure.

PRS portability: The biggest limitation in AI GWAS population genomics

One of the most significant practical limitations in applying ML to population genomics is the poor transferability of PRS models across genetic ancestries. GWAS summary statistics, and therefore PRS models, have been derived predominantly from individuals of European ancestry: approximately 78% of individuals in the GWAS Catalog as of January 2024 had European ancestry. PRS models trained in European-ancestry cohorts consistently underperform when applied to non-European-ancestry individuals, because LD patterns, allele frequencies, and effect sizes differ across populations.

A 2023 analysis published in Nature demonstrated that PRS accuracy decreases individual-to-individual along the continuum of genetic ancestries, not just between traditionally defined population groups, even within cohorts labeled as ancestrally homogeneous. This finding has direct implications for how ML-based PRS models should be evaluated: population-level summary metrics such as variance explained can obscure substantial individual-level variation in prediction accuracy.

Multi-ancestry PRS methods, including PRS-CSx and cross-ancestry Bayesian approaches, use GWAS summary statistics from multiple ancestry groups jointly to produce scores that are more transferable. ML methods that incorporate ancestry-specific LD reference panels and learn ancestry-adaptive shrinkage have shown improved cross-ancestry performance. However, the fundamental constraint is data: improving PRS equity requires more diverse and well-powered GWAS training cohorts, not only more sophisticated algorithms applied to existing data.

AI for GWAS drives gains in interpretation, not just discovery

The net contribution of AI and ML to GWAS is most accurately characterized as an improvement in interpretation rather than in discovery. The core statistical machinery of association testing is mature; what limits scientific progress is the difficulty of moving from a list of significant loci to an understanding of which variants are causal, which genes they regulate, and in which cell types the regulatory effect is operative.

AI tools address each of these steps. Sequence-based deep learning models assign predicted functional impact to individual variants within associated loci. Integrative ML frameworks combine multiple lines of functional evidence into unified prioritization scores. Bayesian and ML-based PRS methods extract more predictive signal from existing summary statistics. More sophisticated population modeling approaches further reduce the contribution of ancestry confounding to association results.

The field's remaining challenges are primarily about data rather than algorithms: the dominance of European-ancestry cohorts in GWAS databases limits the generalizability of both association findings and PRS models. The National Human Genome Research Institute-European Bioinformatics Institute (NHGRI-EBI) GWAS Catalog and emerging initiatives are actively working to address cohort diversity, and researchers building AI GWAS workflows should treat ancestry-stratified validation as a baseline requirement. GWAS findings increasingly intersect with multiomics data integration, where ML methods connect genetic association signals to transcriptomic, epigenomic, and proteomic layers to build richer mechanistic models. For researchers approaching these methods as part of a broader computational toolkit, the foundational principles are covered in this AI in life sciences guide, and the wider genomics context in ML for genomics.

This content includes text that has been created with the assistance of generative AI and has undergone editorial review before publishing. Technology Networks' AI policy can be found here.